01 1B.V. KATWIJK CHEMIE
01 1OXAPROZIN
01 1Netherlands
NDC Package Code : 17349-0008
Start Marketing Date : 1995-01-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
71
PharmaCompass offers a list of Oxaprozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxaprozin manufacturer or Oxaprozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxaprozin manufacturer or Oxaprozin supplier.
PharmaCompass also assists you with knowing the Oxaprozin API Price utilized in the formulation of products. Oxaprozin API Price is not always fixed or binding as the Oxaprozin Price is obtained through a variety of data sources. The Oxaprozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Wy-21,743 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Wy-21,743, including repackagers and relabelers. The FDA regulates Wy-21,743 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Wy-21,743 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Wy-21,743 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Wy-21,743 supplier is an individual or a company that provides Wy-21,743 active pharmaceutical ingredient (API) or Wy-21,743 finished formulations upon request. The Wy-21,743 suppliers may include Wy-21,743 API manufacturers, exporters, distributors and traders.
click here to find a list of Wy-21,743 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Wy-21,743 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Wy-21,743 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Wy-21,743 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Wy-21,743 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Wy-21,743 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Wy-21,743 suppliers with NDC on PharmaCompass.
We have 1 companies offering Wy-21,743
Get in contact with the supplier of your choice:
